Market Place
Sourcing Support
All News #Library
Biotech
Ashvattha Appoints Life Healthcare Veteran George Montgomery
08 Jan 2026 //
BUSINESSWIRE
Ashvattha Therapeutics To Present Phase 2 Results & FDA Update
17 Nov 2025 //
GLOBENEWSWIRE
Ashvattha Therapeutics to Present Novel Nanomedicine Radiotracers
17 Jun 2025 //
GLOBENEWSWIRE
Ashvattha Therapeutics to Present Phase 2 Results at ARVO
07 May 2025 //
GLOBENEWSWIRE
Ashvattha Therapeutics to Participate in Upcoming Investor Conferences
14 Feb 2024 //
GLOBENEWSWIRE
Ashvattha Announces the Appointment of Mehdi Paborji as Senior Vice President
04 Jan 2024 //
GLOBENEWSWIRE
Ashvattha Therapeutics to Participate in Upcoming Ophthalmology Conferences
20 Nov 2023 //
GLOBENEWSWIRE
Ashvattha Announces First Patient Dosed of Anti-Angiogenic Therapeutic D-4517.2
01 Nov 2023 //
GLOBENEWSWIRE
Ashvattha Announces Appointment of Dr. Sakura Minami as Vice President
09 Oct 2023 //
GLOBENEWSWIRE
Ashvattha Announces Presentation of Data on Dendranib Nanomedicine Candidate
15 Aug 2023 //
GLOBENEWSWIRE
Ashvattha Appoints Paul E. Cayer as CFO and Mahesh Karande to Board of Directors
31 May 2023 //
GLOBENEWSWIRE
Ashvattha Presents Preclinical Data on anti-VEGF Nanomedicine D-4517.2
26 Apr 2023 //
GLOBENEWSWIRE
Ashvattha Therapeutics Presented Promising Preclinical Data on Novel Macrophage
18 Apr 2023 //
GLOBENEWSWIRE
Ashvattha Therapeutics to Present at Biotech Showcase 2023
03 Jan 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.